Zirabev
List of products in the National Drug Code with proprietary name zirabev. This medication is a man-made antibody (IgG1) used to treat various types of cancer. This drug works by blocking a certain protein (vascular endothelial growth factor-VEGF) thereby decreasing the blood supply to the tumor and slowing tumor growth. This monograph is about the following bevacizumab products: bevacizumab, bevacizumab-awwb, and bevacizumab-bvzr.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
|---|---|---|---|---|---|---|
| 0069-0315 | Zirabev | Bevacizumab-bvzr | Injection, Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
| 0069-0342 | Zirabev | Bevacizumab-bvzr | Injection, Solution | Intravenous | Pfizer Laboratories Div Pfizer Inc | Human Prescription Drug |
